Pfizer, Atavistik
Atavistik Bio enters research collaboration with Pfizer to accelerate discovery of novel precision allosteric therapeutics
Atavistik Bio enters research collaboration with Pfizer to accelerate discovery of novel precision allosteric therapeutics: Cambridge, Massachusetts Friday, January 3, 2025, 15:00
Atavistik Bio collaborates with Pfizer to discover allosteric therapeutics
Atavistik Bio Inc. has entered into a research collaboration with Pfizer Inc. to accelerate the discovery of novel precision allosteric therapeutics for unmet medical needs. Under the collaboration, Atavistik Bio will leverage its proprietary AMPS platform to identify novel allosteric binders against two undisclosed targets selected by Pfizer.
This partnership could redefine precision medicine with groundbreaking therapeutics targeting "impossible" proteins.
3d
Biotechnology company Atavistik Bio announced Thursday that it has entered into a research collaboration with Pfizer, Inc. (PFE) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback